1. March WA，Moore VM，Willson KJ，et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod，2010，25（2）; 544-551.

2. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome（PCOS）. Hum Reprod，2004，19（1）: 41-47.

3. Azziz R，Woods KS，Reyna R，et al.The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab，2004，89（6）: 2745-2749.

4. Knochenhauer ES，Key TJ，Kahsar-Miller M，et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab，1998，83（9）; 3078-3082.

5. Asunción M，Calvo RM，Millán JLS，et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab，2000，85（7）; 2434-2438.

6. Diamanti-Kandarakis E，Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev，2012，33（6）; 981-1030.

7. Azziz R，Marin C，Hoq L，et al. Health care-related economic burden of the polycystic ovary syndrome during the reproduc tive life span. J Clin Endocrinol Metab，2005，90（8）; 4650-4658.

8. Goverde AJ，van Koert AJ，Eijkemans MJ，et al. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. Hum Reprod，2009，4（3）; 710-717.

9. Kaplan PF，Patel M，Austin DJ，et al. Assessing the risk of multiple gestation in gonadotropin intrauterine insemination cycles. Am J Obstet Gynecol，2002，186（6）; 1244-1247.

10. Eijkemans MJ，Imani B，Mulders AG，et al. High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility（WHO 2）. Hum Reprod，2003，18（11）; 2357-2362.

11. 《多囊卵巢综合征诊断》，中华人民共和国卫生行业标准，2011年版，中华医学会妇产科学分会内分泌学组.